- Company Overview for HALEON UK HOLDING CANADA LIMITED (12342809)
- Filing history for HALEON UK HOLDING CANADA LIMITED (12342809)
- People for HALEON UK HOLDING CANADA LIMITED (12342809)
- More for HALEON UK HOLDING CANADA LIMITED (12342809)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
08 Apr 2022 | RESOLUTIONS |
Resolutions
|
|
06 Apr 2022 | TM01 | Termination of appointment of Glaxo Group Limited as a director on 1 April 2022 | |
06 Apr 2022 | TM01 | Termination of appointment of Edinburgh Pharmaceutical Industries Limited as a director on 1 April 2022 | |
06 Apr 2022 | AP02 | Appointment of Gsk Consumer Healthcare Holdings No.8 Limited as a director on 1 April 2022 | |
06 Apr 2022 | AP02 | Appointment of Gsk Consumer Healthcare Holdings No.4 Limited as a director on 1 April 2022 | |
09 Mar 2022 | TM01 | Termination of appointment of David John Cottam as a director on 4 March 2022 | |
09 Mar 2022 | AP01 | Appointment of Mr Lee Di Pietro as a director on 4 March 2022 | |
14 Dec 2021 | CS01 | Confirmation statement made on 1 December 2021 with no updates | |
02 Nov 2021 | AA | Full accounts made up to 31 December 2020 | |
23 Dec 2020 | CS01 | Confirmation statement made on 1 December 2020 with updates | |
17 Aug 2020 | AP01 | Appointment of Mr Thomas Ian Whittle as a director on 31 July 2020 | |
13 Aug 2020 | TM01 | Termination of appointment of Antrinkos Andrew Aristidou as a director on 31 July 2020 | |
18 Mar 2020 | AP01 | Appointment of Mr. David John Cottam as a director on 10 March 2020 | |
30 Dec 2019 | SH01 |
Statement of capital following an allotment of shares on 13 December 2019
|
|
02 Dec 2019 | NEWINC |
Incorporation
Statement of capital on 2019-12-02
|